S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
Critical asset just had biggest fall on record (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
What to watch for as China's major political meeting of the year gets underway
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
OTCMKTS:WUXAY

WuXi AppTec (WUXAY) Stock Price, News & Analysis

$6.50
+0.23 (+3.67%)
(As of 03/1/2024 ET)
Today's Range
$6.36
$6.52
50-Day Range
$4.99
$10.44
52-Week Range
$4.84
$13.02
Volume
4,191 shs
Average Volume
23,574 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

WUXAY stock logo

About WuXi AppTec Stock (OTCMKTS:WUXAY)

WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical testing services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.

WUXAY Stock Price History

WUXAY Stock News Headlines

Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
WuXi AppTec Co. Ltd. ADR
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
WuXi AppTec Reports Record Results in 2022
WUXAY WuXi AppTec Co., Ltd.
See More Headlines
Receive WUXAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for WuXi AppTec and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
OTCMKTS:WUXAY
CIK
N/A
Fax
N/A
Employees
41,148
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Dr. Ge Li Ph.D. (Age 57)
    Co-Founder, Chairman, President & CEO
    Comp: $5.84M
  • Dr. Minzhang Chen Ph.D. (Age 54)
    Co-CEO & Executive Director
    Comp: $1.38M
  • Dr. Qing Yang Ph.D. (Age 55)
    Co-CEO & Executive Director
    Comp: $1.19M
  • Dr. Edward Hu M.B.A. (Age 61)
    Vice Chairman of the Board & Global Chief Investment Officer
    Comp: $1.48M
  • Mr. Zhaohui Zhang (Age 54)
    COO of China, VP & Executive Director
    Comp: $1.05M
  • Ms. Ming Shi (Age 49)
    Senior VP & CFO
  • Mr. Kyler Lei
    IR Director
  • Dr. Howard Wu J.D.
    Senior VP, General Counsel & Global Head of Human Resources
  • Dr. Shuhui Chen Ph.D. (Age 60)
    Executive Vice President & Head of DDSU
  • Dr. Jingchao Dong Ph.D.
    Senior VP & Head of RCS














WUXAY Stock Analysis - Frequently Asked Questions

How have WUXAY shares performed in 2024?

WuXi AppTec's stock was trading at $10.1450 at the beginning of 2024. Since then, WUXAY shares have decreased by 35.9% and is now trading at $6.50.
View the best growth stocks for 2024 here
.

Are investors shorting WuXi AppTec?

WuXi AppTec saw a increase in short interest in February. As of February 15th, there was short interest totaling 3,300 shares, an increase of 1,550.0% from the January 31st total of 200 shares. Based on an average daily trading volume, of 24,400 shares, the days-to-cover ratio is presently 0.1 days.
View WuXi AppTec's Short Interest
.

How do I buy shares of WuXi AppTec?

Shares of WUXAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:WUXAY) was last updated on 3/3/2024 by MarketBeat.com Staff